Mir-24-3p downregulation contributes to VP16–DDP resistance in small-cell lung cancer by targeting ATG4A

por Pan, Banzhou, Chen, Yitian, Song, Haizhu, Xu, Yichen, Wang, Rui, Chen, Longbang
Publicado 2014

LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1

por Huang, Jiayuan, Pan, Banzhou, Xia, Guohao, Zhu, Jingni, Li, Chenchen, Feng, Jifeng
Publicado 2020

HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma

por Pan, Banzhou, Chen, Dongqin, Huang, Jiayuan, Wang, Rui, Feng, Bing, Song, Haizhu, Chen, Longbang
Publicado 2014

MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma

por Pan, Banzhou, Feng, Bing, Chen, Yitian, Huang, Guichun, Wang, Rui, Chen, Longbang, Song, Haizhu
Publicado 2015

Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung C...

por Chen, Yuzhong, Wen, Shaodi, Xia, Jingwei, Du, Xiaoyue, Wu, Yuan, Pan, Banzhou, Zhu, Wei, Shen, Bo
Publicado 2021

Corrigendum: Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Smal...

por Chen, Yuzhong, Wen, Shaodi, Xia, Jingwei, Du, Xiaoyue, Wu, Yuan, Pan, Banzhou, Zhu, Wei, Shen, Bo
Publicado 2021

A Prognostic Risk Model of a Novel Oxidative Stress-Related Signature Predicts Clinical Prognosis and Demonstrates Immune Relevancy in Lung Adenocarcinoma

por Huang, Xing, Lu, Zhichao, He, Min, Feng, Yipeng, Yu, Shaorong, Shen, Bo, Lu, Jianwei, Wu, Pingping, Pan, Banzhou, Ding, Hanlin, Chen, Chen, Sun, Yidan
Publicado 2022

Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: a retrospective study

por Du, Xiaoyue, Wen, Shaodi, Shi, Run, Xia, Jingwei, Wang, Ruotong, Zhang, Yihan, Pan, Banzhou, Wu, Xiaoliu, Zhu, Wei, Feng, Jifeng, Wang, Xin, Shen, Bo
Publicado 2023

TFAP2C-Activated MALAT1 Modulates the Chemoresistance of Docetaxel-Resistant Lung Adenocarcinoma Cells

por Chen, Jing, Liu, Xiaobei, Xu, Yichen, Zhang, Kai, Huang, Jiayuan, Pan, Banzhou, Chen, Dongqin, Cui, Shiyun, Song, Haizhu, Wang, Rui, Chu, Xiaoyuan, Zhu, Xiaoli, Chen, Longbang
Publicado 2019

Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial

por Wu, Yuan, Zhou, Xuefeng, Zhao, Weiqing, Wang, Qiong, Han, Zhengxiang, Wang, Lifeng, Zhou, Wenjie, Zhou, Tong, Song, Haizhu, Chen, Yong, Yang, Kaihua, Shi, Lin, Pan, Banzhou, Guo, Renhong, Zhou, Guoren, Jiang, Feng, Feng, Jifeng, Shen, Bo
Publicado 2023

An exploration of the clinical progression models of osimertinib in the treatment of advanced EGFR-mutant non-small cell lung cancer

por Shi, Yue, Jiang, Yingying, Pan, Banzhou, Wang, Zihan, Li, Hang, Ma, Yuxin, Liu, Yilin, He, Kang, Wang, Zhitong, Lu, Jianwei, Shi, Meiqi, Shen, Bo, Zhou, Guoren, Yin, Rong, Rossi, Antonio, Ito, Kentaro, Santarpia, Mariacarmela, Um, Sang-Won, Wang, Xiaohua, Chen, Cheng, Feng, Jifeng
Publicado 2022